Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 42.09 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.67 | +1.62% | 42.09 | 42.19 | 41.47 | 41.48 | 41.42 | 16:02:34 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 100,700 | 24,583,231 | $ 41.9568 | $ 1.03B | 16.15M | 32.32 - 42.19 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:39 | formt | 300 | $42.09 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 246.74B | 5.86B | $ 21.31B | 3.57 | 0.00 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.36 | 3.23% | 08/02/2018 | -683.67k | 76.00% |
Pfizer, Inc. News
Pfizer, BioNTech in $425 Million Flu Vaccine Collaboration Dow Jones News • Thu Aug 16, 2018 7:03 AM (3 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Aug 14, 2018 5:07 PM (4 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Aug 14, 2018 5:07 PM (4 days ago)
Gemphire Therapeutics Shares Fall Over 50% in Heavy Trading -- Market Mover Dow Jones News • Fri Aug 10, 2018 11:33 AM (1 week ago)
Quarterly Report (10-q) Edgar (US Regulatory) • Thu Aug 09, 2018 4:34 PM (1 week ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Mon Aug 06, 2018 3:20 PM (2 weeks ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Fri Aug 03, 2018 3:39 PM (2 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 40.81 | 42.19 | 40.54 | 41.0526 | 12M | 25M | 14M | 1.28 | 3.14% |
| 1 Month | 37.2 | 42.19 | 37.12 | 39.8773 | 11M | 42M | 19M | 4.89 | 13.15% |
| 3 Months | 35.82 | 42.19 | 35.32 | 37.8214 | 9M | 42M | 17M | 6.27 | 17.50% |
| 6 Months | 35.76 | 42.19 | 34.32 | 36.7549 | 9M | 43M | 18M | 6.33 | 17.70% |
| 1 Year | 32.91 | 42.19 | 32.32 | 36.2704 | 6M | 49M | 17M | 9.18 | 27.89% |
| 3 Years | 34.24 | 42.19 | 28.25 | 33.5054 | 6M | 280M | 23M | 7.85 | 22.93% |
| 5 Years | 28.14 | 42.19 | 27.51 | 32.6065 | 1k | 280M | 24M | 13.95 | 49.57% |
Pfizer, Inc. Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
